VHL and nonpapillary renal cell carcinoma: This analysis demonstrated the poor performance of the aforementioned tools in distinguishing between ccRCC and non-ccRCC causing mutations on this newly curated data set, demonstrating the need for a novel and optimized model to assist on VHL patient risk stratification.